Reports Q1 revenue $540.6M, consensus $541.55M. “The year is progressing as planned, and we have successfully raised capital at attractive prices to support our anticipated external investments and development initiatives, all while preserving ample capacity to pursue opportunistic growth,” said CEO Danny Prosky. “Despite a challenging winter season, strong demand for long-term care led to great performance for our diversified healthcare portfolio, as demand helped mitigate any previously anticipated occupancy losses during the quarter. Our regional operating partners played a critical role in delivering high-quality care during this period, particularly within our higher-acuity long-term care settings. For the balance of 2025, we expect demand to continue strengthening as we enter the warmer spring and summer selling seasons.”
Confident Investing Starts Here:
- Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- Strategic Growth and Demographic Trends Justify Buy Rating for American Healthcare REIT, Inc.
- American Healthcare REIT initiated with a Buy at Jefferies
- American Healthcare REIT price target lowered to $34 from $35 at KeyBanc
- American Healthcare REIT price target raised to $37 from $36 at Morgan Stanley
- American Healthcare REIT management to meet with KeyBanc